SPYGLASS PHARMA INC (SGP) Forecast, Price Target & Analyst Ratings

NASDAQ:SGP • US85220G1094

Current stock price

23.98 USD
+1.04 (+4.53%)
At close:
23.98 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SPYGLASS PHARMA INC (SGP).

Forecast Snapshot

Consensus Price Target

Price Target
$45.90
+ 91.41% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.51
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
88.89%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$45.90
Upside
+ 91.41%
From current price of $23.98 to mean target of $45.90, Based on 9 analyst forecasts
Low
$37.37
Median
$42.84
High
$65.10

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for SGP. The average price target is 45.9 USD. This implies a price increase of 91.41% is expected in the next year compared to the current price of 23.98.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SGP Current Analyst RatingSGP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

SGP Historical Analyst RatingsSGP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
88.89%
SGP was analyzed by 9 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about SGP.
SGP was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-10HC Wainwright & Co.Initiate Buy
2026-03-03Leerink PartnersInitiate Outperform
2026-03-03StifelInitiate Buy
2026-03-03CitigroupInitiate Buy
2026-03-03JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.51
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SGP revenue by date.SGP revenue by date.
N/AN/AN/AN/AN/A
226.51%		N/A
150.20%		N/A
62.00%		N/A
42.42%
EBITDA
YoY % growth
SGP ebitda by date.SGP ebitda by date.
-28.338M-53.857M
-90.05%		-82.286M
-52.79%		N/A
31.31%		N/A
-4.21%		N/A
-7.73%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
SGP ebit by date.SGP ebit by date.
-28.461M-54.128M
-90.19%		-82.898M
-53.15%		N/A
22.63%		N/A
-24.41%		N/AN/AN/A
-11.54%		N/A
33.93%		N/A
79.80%		N/A
486.70%
Operating Margin
SGP operating margin by date.SGP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SGP eps by date.SGP eps by date.
N/AN/AN/AN/A
8.04%		N/A
-15.90%		N/A
-7.80%		N/A
-20.96%		N/A
-9.41%		N/A
35.35%		N/A
80.30%		N/A
482.50%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.51-0.43-0.46-0.49-0.41
18.52%		-0.45
-5.04%		-0.49
-6.57%		-0.55
-11.11%		-0.59
-41.46%		-0.68
-48.89%		-0.91
-83.67%		-1.08
-98.15%
Revenue
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-12.18M-12.993M-14.984M
43.89%		-16.369M
59.92%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-14.253M-15.042M-16.33M
39.74%		-17.238M
58.41%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SGP Yearly Revenue VS EstimatesSGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 200M 400M 600M
SGP Yearly EPS VS EstimatesSGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-4.74%
EPS Next 5 Year
-8.74%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-14.31%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SPYGLASS PHARMA INC / SGP Forecast FAQ

What is the price target for SGP stock?

9 analysts have analysed SGP and the average price target is 45.9 USD. This implies a price increase of 91.41% is expected in the next year compared to the current price of 23.98.

Can you provide the consensus estimates for SPYGLASS PHARMA INC next earnings?

The consensus EPS estimate for the next earnings of SPYGLASS PHARMA INC (SGP) is -0.51 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for SGP stock?

The consensus rating for SPYGLASS PHARMA INC (SGP) is 88.8889 / 100 . This indicates that analysts generally have a positive outlook on the stock.